Paul Farrow
Paul Farrow is an Associate Fellow at Green Templeton College, University of Oxford. He is Executive Director at Oxford PharmaGenesis, an award-winning, global HealthScience communications consultancy that helps the healthcare industry, academia and patient groups to communicate medical evidence effectively.
Paul studied biological sciences at the University of Birmingham (1997 to 2001) before completing a DPhil in molecular medicine at then-Green College (2005). He later joined Oxford PharmaGenesis as a trainee Medical Writer. Growing with the company and building strong client relationships, he now co-leads the company’s operations in the Europe region. Recipient of the Queen’s Award for Outstanding Achievement in International Trade (2019), Oxford PharmaGenesis now has more than 500 employees loosely based around offices in Oxford, London, Cardiff, Cambridge, Melbourne and Philadelphia.
Paul believes that demonstrable ethical practices, transparency, and education are essential to building trust in pharma-sponsored research. He has served on the educational programme committee for the European meetings of the International Society for Medical Publication Professionals and for over a decade has taught publication ethics to postgraduate students on the MSc Experimental and Translational Therapeutics course at the University of Oxford.
He also co-founded the Open Pharma initiative, which brings together top pharma companies, publishers, patients, regulators, non-pharma funders and academic societies to learn from the open science movement and drive positive change in how pharma-sponsored research is communicated.
